• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Catalog Number RONYX25015X
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problems Angina (1710); Myocardial Infarction (1969)
Event Date 06/29/2018
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
During the index procedure one resolute onyx des was implanted in the 1st obtuse marginal.Approximately 4 days later the patient suffered exertional angina.It was indicated that the exertional angina was related to a myocardial infarction.It is unknown if the target vessel was involved.Investigator assessed the event as possibly related to the index device and unlikely related to the anti-platelet medication.Patient is recovering.
 
Manufacturer Narrative
Event date was updated.The event term was updated to myocardial infarction.Investigator assessed that the event was not related to index device or anti-platelet medication.The sponsor assessed the event as possibly related to anti-platelet medication.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Sponsor assessed the event as not related to the index device.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
The event was treated by revascularization with the implantation of one resolute onyx des in the lad.This has been classified as a non target lesion revascularization and the target vessels were not involved.Cec adjudicated the mi as non q wave mi (non target vessel) and adjudicated the revascularization as non tvr percutaneous intervention (ntvr).If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Cec adjudicated that the mi was a non event.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
The patient recovered.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE ONYX RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key7689061
MDR Text Key114007539
Report Number9612164-2018-01738
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
P160043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 05/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/16/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/26/2019
Device Catalogue NumberRONYX25015X
Device Lot Number0008798068
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/18/2019
Date Device Manufactured07/26/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age82 YR
Patient Weight73
-
-